Letter to the Editor Open Access
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 101938
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.101938
Current opinions on the use of prophylactic antibiotics in patients undergoing laparoscopic cholecystectomy
Efstathios T Pavlidis, Ioannis N Galanis, Theodoros E Pavlidis, The Second Department of Propaedeutic Surgery, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki 54642, Greece
ORCID number: Efstathios T Pavlidis (0000-0002-7282-8101); Ioannis N Galanis (0009-0001-4283-0788); Theodoros E Pavlidis (0000-0002-8141-1412).
Author contributions: Pavlidis TE designed research, contributed new analytic tools, analyzed data, review and approved the paper; Galanis IN analyzed data, review and approved the paper; Pavlidis ET performed research, analyzed data, review and wrote the article.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Theodoros E Pavlidis, PhD, Doctor, Emeritus Professor, Surgeon, The Second Department of Propaedeutic Surgery, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Konstantinoupoleos 49, Thessaloniki 54642, Greece. pavlidth@auth.gr
Received: October 2, 2024
Revised: January 17, 2025
Accepted: January 23, 2025
Published online: March 27, 2025
Processing time: 145 Days and 0.2 Hours

Abstract

Inappropriate use of antibiotics leads to microbial resistance. Single-dose antibiotic prophylaxis prior to laparoscopic cholecystectomy is well known for reducing the risk of postoperative infection in high-risk patients despite some conflicting aspects. High-risk patients are those who are older than 70 years, have diabetes mellitus, whose operation time exceeded 120 minutes, have acute cholecystitis, experienced iatrogenic intraoperative gallbladder perforation resulting in bile or gallstone spillage, suffered from obstructive jaundice, or were deemed immunocompromised. For gallbladder perforation, one dose of antibiotic prophylaxis is sufficient. Therefore, guidelines are needed and must be strictly followed. Prophylactic treatment is not needed for patients at low risk of developing sepsis following elective laparoscopic cholecystectomy, although the opposite is supported. Similarly, superficial surgical infections are related to low morbidity. Patients without risk factors have a very low risk of infection. Thus, the routine use of antibiotic prophylaxis in elective laparoscopic cholecystectomy is not recommended.

Key Words: Prophylactic antibiotics; Gallstone disease; Laparoscopic cholecystectomy; Acute cholecystitis; Skin incision infection; Septic complications

Core Tip: In the most cases of elective laparoscopic cholecystectomy, there is a low possibility of septic complication development and no need for prophylactic antibiotics. In few patients with some well-defined risk factors for infection, including acute cholecystitis, the antibiotic prophylaxis before skin incision is necessary to minimize such complications.



TO THE EDITOR

Clinicians must be careful in deciding to administer antibiotics for prophylaxis, as there is a risk of microbial resistance in the event of excessive use or abuse. Microbial resistance has become a source of major concern worldwide, as new, more powerful, antibiotics are being discovered to treat severe infections refractory to previously effective treatment methods. Perioperative antibiotic prophylaxis has been used in patients scheduled for elective and emergency operative procedures[1]. Laparoscopic simple cholecystectomy for uncomplicated cholelithiasis is related to a very low risk of infection[2,3], since the bile entering the biliary tree is typically aseptic; however, impeded flow of bile is known to promote the growth of microbes, especially in patients of an advanced age[4,5]. Wang[6] recently published a retrospective study in the World Journal of Gastrointestinal Surgery evaluating the risk factors for surgical site infections and the effectiveness of prophylactic antibiotics in patients undergoing laparoscopic cholecystectomy and reported very interesting outcomes.

Single-dose intravenous antibiotic prophylaxis at the beginning of laparoscopic cholecystectomy is well known for preventing the risks of skin incision infections or other septic complications in high-risk patients[6,7-10], despite the existence of some conflicting aspects and the opposite supporting no antibiotic prophylaxis at all[11-15]. High-risk patients are those who are older than 70 years, have diabetes mellitus, whose surgery duration exceeded 120 minutes, were diagnosed with acute cholecystitis, suffered from iatrogenic intraoperative gallbladder perforation resulting in bile or gallstone spillage, experienced obstructive jaundice, and were deemed immunocompromised[6,7,15,16]. The timing, selection, and duration of perioperative antibiotic prophylaxis for skin wound infections are the determining factors[11,12]. However, guidelines are needed and strict adherence is required for all medical and nursing staff[17].

Antibiotic prophylaxis is not required for patients at low risk of developing sepsis after elective laparoscopic cholecystectomy; however, in addition to the most appropriate surgical technique, meticulous application of alternative infection prevention measures with antiseptic protocols and thorough preoperative preparation, is needed for such patients[18-22]. However, the opposite has been supported. The argument for the latter opinion is based on a meta-analysis that revealed a reduction in the incidence of surgical site infections and distant or overall infections after antibiotic prophylaxis[23].

In addition, superficial surgical infections such as skin incision infections are unlikely to lead to morbidity[24]. Therefore, patients without risk factors have a very low risk of infection and do not need prophylactic antibiotics[1,25,26].

The World Health Organization has general guidelines for the prevention of surgical site infections in patients undergoing any surgical procedure, particularly cardiothoracic and orthopedic procedures, mainly for Staphylococcus aureus, where beta-lactam antibiotics play a dominant role as well as other prophylactic measures[27]. Elective laparoscopic cholecystectomy has a low risk for such infection.

Strong evidence-based guidelines for laparoscopic cholecystectomy do not exist, and there is ongoing debate. The United States of America Surgical Infection Society recognizes the need for better evidence in guidelines focusing on the appropriate use of antibiotics in patients undergoing laparoscopic cholecystectomy. They recommend the following: (1) No routine perioperative prophylactic antibiotic use in patients undergoing elective operations, only selective use in high-risk cases; (2) No use for symptomatic cholelithiasis; (3) No use for mild or even moderate acute cholecystitis; and (4) Use only for severe inflammation according to the Tokyo classification for a maximum of 4 days[28].

Identifying any risk factor for infection is the first step in diagnosis[6]. Liver function tests (transaminases, bilirubin, alkaline phosphatase, and gamma-glutamyl transferase) are necessary before every cholecystectomy. Elevations in such markers indicate cholestasis, and gallstone disease found on biliary ultrasound warrant magnetic resonance cholangiopancreatography (MRCP)[29].

Gallbladder bile samples for culture obtained via paracentesis under imaging guidance can be helpful in the event that inflammation markers (white blood cell count, polymorphonuclear cell count, and c-reactive protein level) are elevated or that imaging is not possible, indicating acute gallbladder inflammation; however, there are practical challenges and limitations in routine clinical practice[4,5].

Elderly patients, patients with symptoms, and patients who undergo preoperative endoscopic retrograde cholangiopancreatography (ERCP) are more likely to have a positive bile culture[5].

In the case of concomitant common bile duct stones on MRCP, the recommendation is ERCP-endoscopic sphincterotomy and stone removal, followed by laparoscopic cholecystectomy[29], at which time antibiotic prophylaxis is necessary[5]. Bile culture-based antibiotics are more effective than empiric antibiotics after ERCP and in cases of acute cholecystitis[5,13].

Researchers have previously postulated that because antibiotic prophylaxis does not provide extra benefit for reducing the risk of postoperative infections and is not cost-effective, its use is not justified, even more so for patients with mild-to-moderate acute cholecystitis undergoing emergency laparoscopic cholecystectomy[12,17,30].

A comparative study revealed that cefazolin (2 g) before anesthesia for elective laparoscopic cholecystectomy in low-risk cases had no impact on the incidence of surgical site infection, with a ratio of 2% in both groups[31]. However, in patients with acute cholecystitis, a recent multicenter randomized controlled trial showed that 2 g of cefazolin before incision was associated with fewer postoperative infections (7.1%) than no antibiotic prophylaxis (12.6%), leading to its undeniable recommendation[17,32].

Prophylactic antibiotics is required for older patients in any case[4]. Additionally, if the operation time is expected to be prolonged, a single dose of 2 g of cefazolin intravenously must be applied before the skin is incised[7].

The most preferred antibiotic for prophylaxis is cefazolin[3,4,18,20,32], a first-generation cephalosporin, but cefuroxime[33], a second-generation cephalosporin or even third-generation ceftriaxone, has also been used in cases of acute cholecystitis[8].

For iatrogenic intraoperative gallbladder perforation and spillage of bile or stones, a single dose of an antibiotic is sufficient, especially in combination with proper cleaning and local irrigation of the operative field[34-36].

Alternatives for patients with beta-lactam allergies or for those undergoing prolonged surgeries who are at risk of gram-negative infections constitute beta-lactamase inhibitors, i.e., mainly among tazobactam (piperacillin with clavulanic acid), ampicillin with sulbactam, third-generation cephalosporins or carbapenems[37].

The routine use of antibiotic prophylaxis in patients scheduled to undergo elective laparoscopic cholecystectomy is not recommended, except in select patients at high risk of infection, including those scheduled for emergency laparoscopic cholecystectomy for mild to moderate acute cholecystitis.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and hepatology

Country of origin: Greece

Peer-review report’s classification

Scientific Quality: Grade C, Grade C, Grade C

Novelty: Grade B, Grade C, Grade D

Creativity or Innovation: Grade B, Grade B, Grade D

Scientific Significance: Grade B, Grade B, Grade C

P-Reviewer: Mukundan A; Saengtienchai A; Tantinam T S-Editor: Fan M L-Editor: A P-Editor: Wang WB

References
1.  Fiallo P, Williams T, Bush LM. When Antimicrobial Treatment and Surgical Prophylaxis Collide: A Stewardship Opportunity. Hosp Pharm. 2024;59:460-464.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
2.  Ely S, Rothenberg KA, Beattie G, Gologorsky RC, Huyser MR, Chang CK. Modern Elective Laparoscopic Cholecystectomy Carries Extremely Low Postoperative Infection Risk. J Surg Res. 2020;246:506-511.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in RCA: 9]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
3.  Sarkut P, Kilicturgay S, Aktas H, Ozen Y, Kaya E. Routine Use of Prophylactic Antibiotics during Laparoscopic Cholecystectomy Does Not Reduce the Risk of Surgical Site Infections. Surg Infect (Larchmt). 2017;18:603-609.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in RCA: 14]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
4.  Oliveira RS, Silva PD, Queiroz CAS, Terra-Júnior JA, Crema E. Prevalence of Bacteriobilia in patients undergoing elective colecystectomy. Arq Bras Cir Dig. 2018;31:e1392.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in RCA: 1]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
5.  Yun SP, Seo HI. Clinical aspects of bile culture in patients undergoing laparoscopic cholecystectomy. Medicine (Baltimore). 2018;97:e11234.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in RCA: 23]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
6.  Wang S. Evaluating risk factors for surgical site infections and the effectiveness of prophylactic antibiotics in patients undergoing laparoscopic cholecystectomy. World J Gastrointest Surg. 2025;17.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
7.  Martzivanou EC, Psarras K, Monioudis P, Vamvakis K, Nikolaidou C, Geropoulos G, Pavlidis ET, Symeonidis N, Pavlidis TE. Perioperative Antibiotic Prophylaxis: An Educative Intervention Significantly Increases Compliance. J Clin Med Res. 2021;13:170-176.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
8.  Sheikh S, Malik NK, Karim BA. Antibiotic prophylaxis and surgical site infections; a prospective open label study to clinically evaluate the serum and tissue concentration of single dose prophylactic ceftriaxone in laparoscopic cholecystectomy. Eur J Clin Pharmacol.  2020.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in RCA: 2]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
9.  Matsui Y, Satoi S, Hirooka S, Kosaka H, Kawaura T, Kitawaki T. Reappraisal of previously reported meta-analyses on antibiotic prophylaxis for low-risk laparoscopic cholecystectomy: an overview of systematic reviews. BMJ Open. 2018;8:e016666.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in RCA: 10]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
10.  Sajid MS, Bovis J, Rehman S, Singh KK. Prophylactic antibiotics at the time of elective cholecystectomy are effective in reducing the post-operative infective complications: a systematic review and meta-analysis. Transl Gastroenterol Hepatol. 2018;3:22.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in RCA: 7]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
11.  Rihan M. Influence of antibiotic prophylaxis on wound infection incidence after elective laparoscopic cholecystectomy. J Perioper Pract. 2024;17504589231223014.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Singh A, Kaur M, Swaminathan C, Subramanian A, Singh KK, Sajid MS. Preoperative antibiotic prophylaxis in acute cholecystectomy: a systematic review and meta-analysis of randomised controlled trials. Transl Gastroenterol Hepatol. 2023;8:37.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
13.  Ierano C, Hall L, James R. Surgical site infection prophylaxis: what have we learned and are we making progress? Curr Opin Infect Dis. 2023;36:450-461.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
14.  Park SE, Choi HJ, You YK, Hong TH. Clinical significance of preoperative antibiotic use in mild to moderate acute inflammatory gallbladder disease: A randomized controlled trial. J Hepatobiliary Pancreat Sci. 2023;30:482-492.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
15.  Gamo GO, Reichardt GS, Guetter CR, Pimentel SK. Risk factors for surgical wound infection after elective laparoscopic cholecystectomy. Arq Bras Cir Dig. 2022;35:e1675.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
16.  Masaod RE, Salih MA. Prevalence and risk factors of post-cholecystectomy surgical site infections. Ann Med Surg (Lond). 2023;85:5428-5432.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
17.  Satheeskaran M, Hussan A, Anto A, de Preux L. Cost-effectiveness analysis of antibiotic prophylaxis versus no antibiotic prophylaxis for acute cholecystectomy. BMJ Open Gastroenterol. 2023;10.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
18.  Ullah K, Dogar AW, Jan Z, Bilal H, Tahir MJ, Hamza A, Asghar MS, Yousuf Z. Role of antibiotic prophylaxis on surgical site infection prevention in a low-risk population undergoing laparoscopic cholecystectomy: A randomized controlled study. Ann Med Surg (Lond). 2022;78:103804.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
19.  Yang JD, Yu HC. Prospective Control Study of Clinical Effectiveness of Prophylactic Antibiotics in Laparoscopic Cholecystectomy on Infection Rate. Yonsei Med J. 2021;62:172-176.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in RCA: 2]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
20.  Liew YX, Chian DM, Koh YX, Chlebicki MP. Reducing prophylactic antibiotics use in laparoscopic cholecystectomy and liver resections. Eur J Gastroenterol Hepatol. 2021;33:533-534.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in RCA: 1]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
21.  Kim SH, Yu HC, Yang JD, Ahn SW, Hwang HP. Role of prophylactic antibiotics in elective laparoscopic cholecystectomy: A systematic review and meta-analysis. Ann Hepatobiliary Pancreat Surg. 2018;22:231-247.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in RCA: 10]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
22.  Macano C, Griffiths EA, Vohra RS. Current practice of antibiotic prophylaxis during elective laparoscopic cholecystectomy. Ann R Coll Surg Engl. 2017;99:216-217.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in RCA: 7]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
23.  Yang J, Gong S, Lu T, Tian H, Jing W, Liu Y, Si M, Han C, Yang K, Guo T. Reduction of risk of infection during elective laparoscopic cholecystectomy using prophylactic antibiotics: a systematic review and meta-analysis. Surg Endosc. 2021;35:6397-6412.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in RCA: 1]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
24.  Briggs KB, Fraser JA, Svetanoff WJ, Staszak JK, Snyder CL, Aguayo P, Juang D, Rentea RM, Hendrickson RJ, Fraser JD, St Peter SD, Oyetunji TA. Review of Perioperative Prophylactic Antibiotic Use during Laparoscopic Cholecystectomy and Subsequent Surgical Site Infection Development at a Single Children's Hospital. Eur J Pediatr Surg. 2022;32:85-90.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
25.  Smith JP, Samra NS, Ballard DH, Moss JB, Griffen FD. Prophylactic Antibiotics for Elective Laparoscopic Cholecystectomy. Am Surg. 2018;84:576-580.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Guler Y, Karabulut Z, Sengul S, Calis H. The effect of antibiotic prophylaxis on wound infections after laparoscopic cholecystectomy: A randomised clinical trial. Int Wound J. 2019;16:1164-1170.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in RCA: 8]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
27.  Hedenstierna G, Perchiazzi G, Meyhoff CS, Larsson A. Who Can Make Sense of the WHO Guidelines to Prevent Surgical Site Infection? Anesthesiology. 2017;126:771-773.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in RCA: 30]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
28.  Colling KP, Besshoff KE, Forrester JD, Kendrick D, Mercier P, Huston JM. Surgical Infection Society Guidelines for Antibiotic Use in Patients Undergoing Cholecystectomy for Gallbladder Disease. Surg Infect (Larchmt). 2022;23:339-350.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
29.  Pavlidis ET, Pavlidis TE. Current management of concomitant cholelithiasis and common bile duct stones. World J Gastrointest Surg. 2023;15:169-176.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (2)]
30.  Jaafar G, Sandblom G, Lundell L, Hammarqvist F. Antibiotic prophylaxis in acute cholecystectomy revisited: results of a double-blind randomised controlled trial. Langenbecks Arch Surg. 2020;405:1201-1207.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in RCA: 7]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
31.  Passos MA, Portari-Filho PE. Antibiotic prophylaxis in laparoscopic cholecistectomy: Is it worth doing? Arq Bras Cir Dig. 2016;29:170-172.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in RCA: 12]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
32.  van Braak WG, Ponten JEH, Loozen CS, Schots JPM, van Geloven AAW, Donkervoort SC, Nieuwenhuijzen GAP, Besselink MG, van Heek TNT, de Reuver PR, Vlaminckx B, Kelder JC, Knibbe CAJ, van Santvoort HC, Boerma D. Antibiotic prophylaxis for acute cholecystectomy: PEANUTS II multicentre randomized non-inferiority clinical trial. Br J Surg. 2022;109:267-273.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in RCA: 1]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
33.  Gomez-Ospina JC, Zapata-Copete JA, Bejarano M, García-Perdomo HA. Antibiotic Prophylaxis in Elective Laparoscopic Cholecystectomy: a Systematic Review and Network Meta-Analysis. J Gastrointest Surg. 2018;22:1193-1203.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in RCA: 12]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
34.  Karabulut Z, Güler Y, Doğan P, Şengül S, Çaliş H. What Should be Done for Perforation of the Gallbladder During Laparoscopic Cholecystectomy: Prophylaxis or Treatment? J Laparoendosc Adv Surg Tech A. 2021;31:54-60.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in RCA: 6]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
35.  van Dijk AH, van der Hoek M, Rutgers M, van Duijvendijk P, Donkervoort SC, de Reuver PR, Boermeester MA. Efficacy of Antibiotic Agents after Spill of Bile and Gallstones during Laparoscopic Cholecystectomy. Surg Infect (Larchmt). 2019;20:298-304.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in RCA: 8]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
36.  Evans L, Sams E, Naguib A, Hajibandeh S, Hajibandeh S. Iatrogenic gallbladder perforation during laparoscopic cholecystectomy and outcomes: a systematic review and meta-analysis. Langenbecks Arch Surg. 2022;407:937-946.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in RCA: 5]  [Reference Citation Analysis (1)]
37.  Kanannejad Z, Pourvali A, Esmaeilzadeh H, Shokouhi Shoormasti R, Reza Fazlollahi M, Fallahpour M, Zaremehrjardi F. Diagnosis and selection of alternative antibiotics in beta-lactams hypersensitivity reactions: Current recommendations and challenges. Int Immunopharmacol. 2023;122:110573.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]